Chiari Malformation Type 2 - 22 Studies Found Completed : Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis : Keratosis : 2005-06-30 : Drug: imiquimod cream imiquimod 5% cream applied in doses ranging from one packet (12.5 mg) to 6 packets Completed : Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body : Healthy Volunteers : 2010-01-28 : Drug: Rotigotine transdermal patch Rotigotine 4.5 mg/10 cm^2 patch applied for 24 hours Completed : A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) : Alzheimer's Disease : 2008-02-14 : Drug: Rivastigmine transdermal patch The study treatment was delivered as a patch sizes 5 and 10 cm^2 co Completed : A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis : Actinic Keratosis : 2013-08-12 : Drug: LEO 43204 Formulation 1 Drug: LEO 43 Completed : Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects : Healthy : 2013-01-03 : Drug: Rotigotine transdermal patch Rotigotine transdermal patch, single-dose application over 24 hours 2 Completed : Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch : Healthy : 2008-11-14 : Drug: testosterone 28 cm2 test Completed : Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis : Actinic Keratosis : 2013-03-25 : Drug: Ingenol mebutate gel Drug: placebo Completed : Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems : Hypogonadism : 2011-03-21 : Drug: testosterone matrix transdermal system Completed : A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel : Actinic Keratoses : 2007-01-24 : Drug: PEP005 Completed : Corneal Cross-Linking Comparing Variables : Unstable Corneas : 2014-03-20 : Drug: Epithelium-On Riboflavin <<< Previous | Next >>>
